Myriad Genetics (MYGN) Share-based Compensation Growth (1y) (2010 - 2026)
Myriad Genetics (MYGN) Share-based Compensation Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 53.85% |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | 10.67% |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -4.92% |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | 11.80% |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | 6.67% |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -9.72% |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | 22.20% |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -17.81% |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | 6.42% |
| 10 | Myriad Genetics | 414.15 Mn | 289.75 Mn | 137.60 Mn | -31.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.58% |
| Dec 31, 2025 | -74.31% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | -26.21% |
| Mar 31, 2025 | -20.83% |
| Dec 31, 2024 | 4.81% |
| Sep 30, 2024 | 6.90% |
| Jun 30, 2024 | 29.46% |
| Mar 31, 2024 | 60.00% |
| Dec 31, 2023 | 26.83% |
| Sep 30, 2023 | 23.40% |
| Jun 30, 2023 | 7.69% |
| Mar 31, 2023 | -25.74% |
| Dec 31, 2022 | -2.38% |
| Sep 30, 2022 | -6.00% |
| Jun 30, 2022 | 16.85% |
| Mar 31, 2022 | 12.22% |
| Dec 31, 2021 | -43.62% |
| Sep 30, 2021 | 19.05% |
| Jun 30, 2021 | -5.32% |